Dovonex (LEO Pharma Inc.)


Welcome to the PulseAid listing for the Dovonex drug offered from LEO Pharma Inc.. This Vitamin D [Chemical/Ingredient],Vitamin D Analog [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: LEO Pharma Inc.
NON-PROPRIETARY NAME: Calcipotriene
SUBSTANCE NAME: CALCIPOTRIENE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Vitamin D [Chemical/Ingredient],Vitamin D Analog [EPC]
ROUTE: TOPICAL
DOSAGE FORM: CREAM
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1996-10-01
END MARKETING DATE: 0000-00-00


Dovonex HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDovonex from LEO Pharma Inc.
LABELER NAME: LEO Pharma Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(ug/g)
START MARKETING DATE: 1996-10-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 50222-260_bcc1c92d-af88-4925-994c-ad41c711204d
PRODUCT NDC: 50222-260
APPLICATION NUMBER: NDA020554

Other CALCIPOTRIENE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.Calcipotriene
G&W Laboratories, Inc.Calcipotriene
Glenmark Pharmaceuticals Inc., USACalcipotriene
Glenmark Pharmaceuticals Inc.,USAcalcipotriene
Impax GenericsCalcipotriene
LEO Pharma Inc.Dovonex
Mayne Pharma LLCSORILUX
Physicians Total Care, Inc.Dovonex
Prasco LaboratoriesCalcipotriene
Sandoz Inc.Calcipotriene
Stiefel Laboratories IncSORILUX
Taro Pharmaceuticals U.S.A., Inc.Calcitrene